Roberts Pharmaceutical Corp. said Friday that its shareholdershave approved a previously announced equity investmentagreement with Yamanouchi Pharmaceutical Co. Ltd.

A U.S. subsidiary of the Tokyo company will buy 4 millionnewly issued shares of Roberts common stock (NASDAQ:RPCX)for $23.84 per share, for a total of $95.4 million.

The purchase will increase the number of shares of Robertsstock outstanding to 13.8 million and give Yamanouchi a 29percent stake in the Eatontown, N.J., company. Yamanouchi willhave up to two seats on Roberts' board.

(c) 1997 American Health Consultants. All rights reserved.